Description
A potent and selective bacterial leucyl-tRNA synthetase inhibitor; active against strains of Enterobacteriaceae (MIC50/90 = 0.5/1 µg/ml) and the non-fermentative Gram-negative clinical isolates P. aeruginosa, A. baumannii, S. maltophilia, and B. cepacid (MIC50/90s = 4/8, 4/8, 2/4, and 8/32 µg/ml, respectively); bacterial resistance led to termination of a Phase II clinical trial,
Formal name: 3-[[(3S)-3-(aminomethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborol-7-yl]oxy]-1-propanol, monohydrochloride
Synonyms: Epetraborole|GSK2251052
Molecular weight: 273.5
CAS: 1234563-16-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases